1 | Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance. (Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ) Proc Natl Acad Sci U S A 2017 Jan 31;114(5):1099-1104 54 Citations |
2 | NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145. (Vodanovic-Jankovic S, Hari P, Jacobs P, Komorowski R, Drobyski WR) Blood 2006 Jan 15;107(2):827-34 105 Citations |
1 | NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. (Regunathan J, Chen Y, Wang D, Malarkannan S) Blood 2005 Jan 01;105(1):233-40 53 Citations |
1 | CD28 signal enhances apoptosis of CD8 T cells after strong TCR ligation. (Yu XZ, Martin PJ, Anasetti C) J Immunol 2003 Mar 15;170(6):3002-6 28 Citations |
1 | Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine. (Orentas RJ, Schauer D, Bin Q, Johnson BD) Cell Immunol 2001 Oct 10;213(1):4-13 56 Citations |
1 | Generation and phenotype of cell lines derived from CF and non-CF mice that carry the H-2K(b)-tsA58 transgene. (Takacs-Jarrett M, Sweeney WE, Avner ED, Cotton CU) Am J Physiol Cell Physiol 2001 Jan;280(1):C228-36 18 Citations |
1 | Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens. (Malarkannan S, Horng T, Eden P, Gonzalez F, Shih P, Brouwenstijn N, Klinge H, Christianson G, Roopenian D, Shastri N) Immunity 2000 Sep;13(3):333-44 76 Citations |
1 | Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction. (Yu XZ, Bidwell S, Martin PJ, Anasetti C) J Immunol 1999 Nov 01;163(9):4780-7 14 Citations |
1 | Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. (Malarkannan S, Horng T, Shih PP, Schwab S, Shastri N) Immunity 1999 Jun;10(6):681-90 91 Citations |
1 | The molecular and functional characterization of a dominant minor H antigen, H60. (Malarkannan S, Shih PP, Eden PA, Horng T, Zuberi AR, Christianson G, Roopenian D, Shastri N) J Immunol 1998 Oct 01;161(7):3501-9 212 Citations |
1 | The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis. (Rodriguez M, Rivera-Quinones C, Murray PD, Kariuki Njenga M, Wettstein PJ, Mak T) J Neurovirol 1997 May;3 Suppl 1:S43-5 10 Citations |
1 | Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice. (Drobyski WR, Majewski D) Blood 1997 Feb 01;89(3):1100-9 39 Citations |
1 | The mouse mammary tumor virus env gene is the source of a CD8+ T-cell-stimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma. (Malarkannan S, Serwold T, Nguyen V, Sherman LA, Shastri N) Proc Natl Acad Sci U S A 1996 Nov 26;93(24):13991-6 23 Citations |
1 | Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts. (Drobyski WR, Majewski D) Blood 1996 Jun 15;87(12):5355-69 11 Citations |
1 | A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. (Malarkannan S, Afkarian M, Shastri N) J Exp Med 1995 Dec 01;182(6):1739-50 63 Citations |
1 | The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. (Malarkannan S, Goth S, Buchholz DR, Shastri N) J Immunol 1995 Jan 15;154(2):585-98 38 Citations |
1 | Distribution of Lyb-4.1 and other membrane antigens on murine lymphoid tumors. (Howe RC, Nelson RS, Rogan KM, Ahmed A, Aiken JJ, Dorf ME, Scherer JC, Sell KW, Humphreys RE) J Natl Cancer Inst 1979 Aug;63(2):375-8 2 Citations |
1 | Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites. (Okuda K, Twining SS, David CS, Atassi MZ) J Immunol 1979 Jul;123(1):182-8 111 Citations |